Clinical trials recruiting in Épagny, France

4

Recruiting trials

6

Conditions

Phase breakdown

Phase 2 3Not applicable 1

Conditions recruiting in Épagny, France

Condition	Trials
Breast cancer	2
Lung cancer	2
Breast Cancer (Early Breast Cancer)	1
Large Cell Neuroendocrine Carcinoma of the Lung	1
Metastatic Triple-Negative Breast Carcinoma	1
NSCLC	1

Recruiting trials in Épagny, France

FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
NCT06393816 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
NCT07661927 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Female
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
NCT06505018 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
NCT06620835 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Épagny, France?

4 recruiting trials have at least one study site in Épagny, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.